Home > News > Northwestern fetches $700 million for drug
December 19th, 2007
Northwestern fetches $700 million for drug
Abstract:
NU sold the rights to Royalty Pharma, a New York-based firm with a history of buying royalty rights from research universities.
Northwestern has been using some of its Lyrica royalties bonanza to fund its drive to become the nation's top nanotechnology research center. The university has vowed to hire more scientific superstars in the coming year, relying on the prestige of its nanotech team and cash from royalty payments to attract more talent.
Source:
chicagotribune.com
Bookmark:
| Related News Press |
Academic/Education
Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||